Many Elderly Patients with Metastatic Renal Cell Carcinoma Benefit from Targeted Therapies

Penn Study Investigated Real-World Treatment Outcomes Among Medicare Patients PHILADELPHIA—Many elderly patients with metastatic renal cell carcinoma (RCC)—who are often underrepresented in clinical trials to treat the kidney cancer—are seeing overall survival benefits from treatment with targeted therapies, according to…